Clinical Trial Detail

NCT ID NCT02935205
Title Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors University of California, Davis
Indications

prostate cancer

Therapies

Enzalutamide + Indomethacin

Age Groups: adult senior

No variant requirements are available.